Suzanne D. Conzen, M.D., is a Professor in the Department of Internal Medicine and Chief of the Division of Hematology and Oncology at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of breast cancer.
Dr. Conzen earned her medical degree at Yale School of Medicine and completed her residency in internal medicine at New York Hospital-Cornell Medical Center. She then received advanced training in hematology and medical oncology through a clinical fellowship at Dartmouth-Hitchcock Medical Center and in molecular oncology through a research fellowship at Dartmouth Medical School. She also holds a master’s degree from the London School of Hygiene & Tropical Medicine.
Certified by the American Board of Internal Medicine in medical oncology, she joined the UT Southwestern faculty in 2019.
An established physician-scientist with multiple National Cancer Institute grants, Dr. Conzen focuses her lab’s research on the role of the glucocorticoid receptor in prostate, breast, and ovarian cancers. Her previous research at the University of Chicago led to the recognition of a role for glucocorticoid receptor signaling in breast cancer biology and, more recently, in cancer progression and therapy-resistance in prostate and ovarian cancer. Dr. Conzen also receives peer-reviewed funding from the Breast Cancer Research Foundation. She has published countless academic articles, contributed chapters to several books, and delivered scores of presentations.
Dr. Conzen is a member of the TBCRG endocrine resistance working group, and she previously served on the CALGB/Alliance breast committee. In addition, she has served as senior editor of Cancer Research and as Chair of the National Institutes of Health’s Cancer Etiology Study Section.
In 2006, she was elected to the American Society for Clinical Investigation.